期刊文献+

斯伐他汀对糖尿病肾病大鼠肾小球系膜细胞p38信号通路的影响 被引量:10

Effect of simvastatin on p38 mitogen-activated protein kinase in rat mesangiul cells
原文传递
导出
摘要 目的研究糖尿病肾病大鼠肾小球系膜细胞p38丝裂原活化蛋白激酶(MAPK)的表达及斯伐他汀对其的影响。方法分别以高糖、糖基化终产物(AGE)及过氧化氢孵育糖尿病大鼠肾小球系膜细胞(RMC),Western印迹法检测RMC的p38MAPK和TGF—β蛋白表达,p38MAPK特异性抑制剂SB203580及斯伐他汀预处理对其影响。结果高糖、AGE及过氧化氢均可单独激活p38MAPK,增加RMC的磷酸化(P)p38MAPK和TGF—β的蛋白表达;SB203580显著抑制TGF—β的蛋白表达(P〈0.05);斯伐他汀抑制p38MAPK的活化并减少TGF—β的蛋白表达(P〈0.05)。结论p38MAPK可能是糖尿病肾病发生的始动信号之一。斯伐他汀可能通过抑制p38MAPK磷酸化而减少TGF—β的蛋白表达。 Objective To investigate the relationship between p38 mitogen-activated protein kinase (p38MAPK) and transforming growth factor-13 (TGF-β), and to explore the effect mechanism of p38MAPK on diabetic nephropathy (DN). Methods Rat mesangial cells (RMC) were separately incubated with high glucose, advanced glycosylation end products (AGE) and H2O2 after pre-treatment of SB203580 (p38MAPK special inhibitor) and simvastatin. The protein expression of p-p38MAPK and TGF-β was examined by Western blot. Results Compared to the eontrol group, high glucose, AGE and H2O2 significantly activated p38MAPK and increased the protein expression of p-p38MAPK and TGF-β (P 〈 0.05). The protein expression of TGF-β was significantly inhibited by SB203580 (P 〈 0.05). Compared to RMC incubated with corresponding stimulations, p-p38MAPK and TGF-β were expressed at a lower level in RMC pre-treated with simvastatin (P 〈 0.05). Conclusions p38MAPK may be one of the initial onset signals of diabetic nephropathy. Simvastatin may effectively attenuate DN progression through down-regulating the expression of TGF-β via p38MAPK.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2007年第2期91-94,共4页 Chinese Journal of Nephrology
基金 黑龙江省自然科学基金(2005009) 黑龙江省卫生厅科研基金(2005-137) 黑龙江省教育厅科研基金(11511184) 中国博士后基金(2004035537)
关键词 斯伐他汀 糖尿病肾病 转化生长因子Β P38丝裂原活化蛋白激酶类 Simvastatin Diabetic nephropathy Transforming growth factor β p38 mitogen-aetivated protein kinase
  • 相关文献

参考文献13

  • 1Tuo QH, Wang C, Yan FX, et al. MAPK pathway mediates the protective effects of onychin on oxidative stress-induced apoptosis in ECV304 endothelial cells, Life Sci, 2004, 76:487-497.
  • 2Takahashi M, Hayashi K, Yoshida K, et al. Epiregulin as a major autocrine/paracrine factor released from ERK-and p38MAPK-activated vascular smooth muscle cells,Circulation, 2003, 108: 2524-2529.
  • 3Chen S, Hong SW, Iglesias-de la Cruz MC, et al. The key role of the transforming growth factorvbeta system in the pathogenesis of diabetic nephropathy, Ren Fail, 2001, 23:471-481.
  • 4Kim SI, Han DC, Lee HB. Levastatin inhibits transforming growth factor-batal 1 expression in diabetic rat glomeruli and cultured rat mesangial cells. J Am Soc Nephrol, 2000, 11:80-87.
  • 5Makita Z, Vlassara H, Cerami A, et al. Immunochemical detection of advanced glycosylation end products in vivo. J Boil Chem, 1992, 267: 5133-5138.
  • 6李艳波,邓华聪,郑丹,李呼伦.P38信号通路对人脐静脉内皮细胞单核细胞趋化蛋白-1表达的影响[J].中华糖尿病杂志(1006-6187),2004,12(4):287-289. 被引量:8
  • 7李艳波,邓华聪,郑丹,李呼伦.硒对人脐静脉内皮细胞P38信号通路和环氧化酶-2表达的影响[J].中华预防医学杂志,2004,38(2):127-127. 被引量:2
  • 8Okada S, Shikata K, Matsuda M, et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes, 2003, 52: 2586-2593.
  • 9Kim NH, Kim KB, Kim DL, et al. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in type 2 diabetes mellitus. Diabet Med, 2004, 21: 545-551.
  • 10Blanc A, Pandey NR, Srivastava AK. Synchronous activation of ERK1/2, p38MAPK and PKB/Akt signaling by H2O2 invascular smooth muscle cells: potential involvement in vascular disease (review). Int J Mol Med, 2003, 11: 229-234.

二级参考文献10

  • 1Martin T, Cardarelli PM, Parry GCN, et al. Cytokine induction of monocyte chemoatractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-κ B and AP-1. Eur J Immunol, 1997,27:1091-1097.
  • 2Meng QH, Polak JM, Edgar AJ, et al. Neutrophils enhance expression of inducible nitric oxide synthase in human normal but not cystic fibrosis bronchial epithelial cells. J Pathology, 2000,190:126-132.
  • 3Porreca E, Di Febbo C, Reale M, et al. Monocyte chemoatractant protein-1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. J Vasc Res, 1997,34:58-65.
  • 4Blandberg FG, Wen P, Dai M, et al. Detection of early atherosclerosis with radiolabeled monocyte chemoattractant protein-1 in prediabetic Zucker rats. Pediatr Radiol, 2002,31:827-835.
  • 5Lee JC, Young PR. Role of CSB/P38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol, 1996,59:152-157.
  • 6Han J, Jiang Y, Li Z, et al. Activation of the transcription factor MEF2C by the MAP kinase P38 in inflammation. Nature, 1997,386:296-299.
  • 7Beyaert R, Cuenda A, Vanden Berghe W, et al. The P38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor. EMBO J, 1996,15:1914-1923.
  • 8Blenis J. Signal transduction via the MAP kinase: proceed at your own RSK. Proc Natl Acad Sci USA, 1996,93:1113-1132.
  • 9Yuh LC, Ya JC, Meei JJ. Monocyte Chemoattractant protein-1 gene and protein expression in atherosclerosis of hypercholesterlemic rabbit. Atherosclerosis, 1999,143:115-123.
  • 10Wrobel K, Garay-Sevilla ME, Nava LE, et al. Novel analytical approach to monitoring advanced glycosylation end products in human serum with on-line spectrophotometric and spectrofluorometric detection in a flow system. Clin Chem, 1997,43:1563-1569.

共引文献8

同被引文献103

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部